Genetic and pharmacologic inhibition of menin in lung adenocarcinoma cell lines and the KrasG12D-driven tumor model results in significant upregulation of PD-L1 while overexpressing menin in lung adenocarcinoma cell lines inhibits PD-L1 expression [365]. The gene discussed is MEN1; the disease is lung adenocarcinoma.